Sustainable Growth Advisers (SGA), an investment management company, released its second-quarter 2026 investor letter for its ...

Alcon (CH0432492467) remains a key player in global eye care, with its stock supported by recurring demand for surgical ...

Alcon Inc. posts 17% core profit growth, raises FY2026 forecast again, and screens 5.52% undervalued via DCF. Click here to ...

With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Aecom ACM to post quarterly earnings of $1.47 ...

Alcon (NYSE:ALC) raised its full-year profitability outlook late Monday and significantly reduced its estimate for tariff-related costs after factoring in an anticipated refund of approximately $60 ...

Alcon has experienced robust Q1 growth, driven by double-digit growth in vision care, particularly in the contact lens market. The company's strong revenue growth is attributed to successful product ...

Alcon stock is trading in a tight late-August range while Q2 2026 results show solid revenue and EPS growth, a stronger UNITY ...

Former Novartis subsidiary Alcon, after targeting the pharmaceutical eye drop scene with a trio of recent drug purchases, is adding another pair of arrows to its ophthalmic quiver. And this time, the ...

Alcon innovations featured in more than 75 abstracts across cataract, refractive, visualization and ocular health1 Clinical data presentations and sponsored symposia to highlight the efficacy of Alcon ...

Alcon Media Group has won its $417.5 million bid to acquire the film catalog of Village Roadshow, which declared bankruptcy this past March. Alcon, which already has films like "Blade Runner 2049," ...